Cargando…

374. Complication with Bacterial Pneumonia in Hospitalized Patients with Coronavirus Disease 2019 (COVID-19)

BACKGROUND: Early reports have indicated widespread empiric antimicrobial usage in patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As data regarding bacterial complications in patients with Coronavirus Disease 2019 (COVID-19) are limited and emerging, it is impor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Minji, Haste, Nina, Legaspi, Jamie, Torriani, Francesca J, Abeles, Shira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776153/ http://dx.doi.org/10.1093/ofid/ofaa439.569

Ejemplares similares

499. Infection with Coronavirus Disease 19 (COVID-19) in Healthcare Personnel with Exposure to COVID-19
por: Kang, Minji, et al.
Publicado: (2020)

2101. Impact of “Code Sepsis” on Antimicrobial Utilization at an Academic Medical Center
por: Kang, Minji, et al.
Publicado: (2019)

437. Asymptomatic Healthcare Worker COVID-19 Testing Program
por: Horton, Lucy E, et al.
Publicado: (2020)

374. Need to Improve Minority Representation through COVID-19 Community Research Partnership
por: Dantuluri, Keerti, et al.
Publicado: (2021)

COVID-19 Vaccine Superstations as a Model to Rapidly Achieve Herd Immunity
por: Keehner, Jocelyn, et al.
Publicado: (2021)

1314. Descriptive Epidemiology of 30-day Readmissions among Survivors of Hospitalization with Bacterial Nosocomial Pneumonia in the US, 2012-2019
por: Zilberberg, Marya, et al.
Publicado: (2021)

521. Predictors of Hospitalization Due to Coronavirus Disease 2019 (COVID-19) at a Veterans Affairs Medical Center
por: Ho, Macy, et al.
Publicado: (2021)

374. Candidemia Management and Associated Clinical Outcomes in Hospitalized Patients: An Opportunity for Antifungal Stewardship
por: Patel, Saloni, et al.
Publicado: (2018)

Real world effectiveness of tixagevimab/cilgavimab (Evusheld) in the Omicron era
por: Chen, Benjamin, et al.
Publicado: (2023)

1472. Frequency of Occurrence and Antimicrobial Susceptibility of Bacteria Isolated from Patients Hospitalized with Bacterial Pneumonia in the United States, Western Europe, and Eastern Europe: Results from the SENTRY Program (2016-2019)
por: Sader, Helio S, et al.
Publicado: (2020)

451. Evaluation of Exposure History in Healthcare Personnel with Coronavirus 2019 Disease
por: Silva, Sandra, et al.
Publicado: (2020)

692. Secondary Infections and Coinfections in Coronavirus Disease 2019 (COVID-19)
por: Kaur, Ikwinder P, et al.
Publicado: (2020)

Implementation of an Automated Electronic Medical Record “Antibiotic Timeout” Alert at a Tertiary, Academic Medical Center
por: James, Charles, et al.
Publicado: (2017)

P374: THROMBOTIC EVENTS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA: EXPERIENCE OF ITALIAN AIEOP CENTERS (2009-2017)
por: Mattera, Raffaele, et al.
Publicado: (2023)

P374: Enhanced hospital hygienic monitoring program 2011-2012 in a acute regional hospital in Hong Kong
por: Lee, WM
Publicado: (2013)

816. Effectiveness of Aseptic Stethoscope Barriers in Allowing Clean Contact for Clostridioides Difficile-Contaminated Stethoscopes
por: Vasudevan, Rajiv S, et al.
Publicado: (2020)

1311. Intrapulmonary Pharmacokinetics of Cefiderocol in Hospitalized and Ventilated Patients Receiving Standard of Care Antibiotics for Bacterial Pneumonia
por: Katsube, Takayuki, et al.
Publicado: (2020)

528. Coronavirus Disease 2019 in Children Cared for at Texas Children’s Hospital: Implications of Repeat Testing on Infection Control Strategies
por: Foster, Catherine, et al.
Publicado: (2020)

A Risk-Based Clinical Decision Support System for Patient-Specific Antimicrobial Therapy (iBiogram): Design and Retrospective Analysis
por: Müller, Lars, et al.
Publicado: (2021)

444. Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers in Southeast Michigan
por: Vahia, Amit T, et al.
Publicado: (2020)

EMB2/374: Evidence and not Evidence-based Products Offered for Smoking Cessation on the World Wide Web
por: Eckldorna, J, et al.
Publicado: (1999)

374. Lymphogranuloma Venereum (LGV) Outbreak Among People Living with HIV (PLWH): Michigan, 2015–2018
por: Convery, Christine, et al.
Publicado: (2019)

374 Indication-based Antimicrobial Derestriction: Ceftazidime Derestriction for Febrile Neutropenia
por: Nash, Colleen B., et al.
Publicado: (2014)

1207. Coronavirus Disease, 2019 (COVID-19) in Long-Term Care Facilities (LTCF): One Large County’s Response, California 2020-2021
por: Chinn, Raymond Y, et al.
Publicado: (2021)

1590. Activity of Meropenem-Vaborbactam and Single-Agent Comparators against Enterobacterales Isolates Including KPC-Producing Isolates, from European Patients Hospitalized with Pneumonia Including Ventilator-Associated Pneumonia (2014-2019)
por: Shorttidge, Dee, et al.
Publicado: (2020)

508. Title Favipiravir for the Treatment of Coronavirus Disease 2019; A Propensity Score Matched Cohort Study
por: Alattar, Rand A, et al.
Publicado: (2021)

432. An Outbreak of Coronavirus Disease, 2019 (COVID-19) in a Skilled Nursing Facility – California, 2021: Description, Mitigation, Challenges, and Opportunities
por: Maletz, Anastasia, et al.
Publicado: (2021)

1298. Validation of Local Pseudomonas aeruginosa Risk Factors in Patients with Community-Onset Bacterial Pneumonia
por: Pizzuti, Morgan, et al.
Publicado: (2021)

The rapidly evolving monkeypox epidemic: A call to action to leave no one behind
por: Strathdee, Steffanie A., et al.
Publicado: (2022)

1261. Antimicrobial Activity of Aztreonam-Avibactam against Gram-negative Bacteria Isolated from Patients Hospitalized with Pneumonia in Europe, Latin America, and Asia in 2019
por: Sader, Helio S, et al.
Publicado: (2020)

2055. Utility of Aspergillus Galactomannan Assay in Allogeneic Stem Cell Transplant Recipients
por: Dagher, Sabeen, et al.
Publicado: (2018)

775. The Burden of Arboviral Infection in the Military Health System, 2011-2019
por: Wellington, Trevor, et al.
Publicado: (2020)

440. Clinical Characteristics of Early Noncritical Hospitalized Patients with Coronavirus Disease 2019 (COVID-19): A Single-Center Retrospective Study in New York City
por: Lee, Michelle, et al.
Publicado: (2020)

537. Outpatient Parenteral Antimicrobial Therapy Readmissions from Post-Acute Care Facilities due to Coronavirus Disease 2019
por: Burnett, Yvonne, et al.
Publicado: (2020)

441. Clinical Characteristics of Pediatric SARS-CoV-2 Infection and Coronavirus Disease 2019 (COVID-19) in Kuwait
por: Alsharrah, Danah Y, et al.
Publicado: (2020)

1521. Risk factors associated with complications of influenza A or B infection, southern Puerto Rico, 2016-2019
por: Perez-Caro, Angel L, et al.
Publicado: (2020)

2781. The Use of Aminoglycosides for Treatment of Urinary Tract Infections in Pediatric Patients, a Carbapenem-Sparing Approach
por: Legaspi, Jamie, et al.
Publicado: (2023)

1147. Sentinel Surveillance of Bacterial Pneumonia in Children Under 5 years Treated in HOMI - Fundación Hospital pediatrico la Misericordia in Bogotá, Colombia 2016-2020
por: Moreno, German Camacho, et al.
Publicado: (2021)

1253. In Vitro Activity of Omadacycline against 7000 Bacterial Pathogens from the United States Stratified by Infection Type (2019)
por: Huband, Michael D, et al.
Publicado: (2020)

419. Diagnostic Utility of a Ferritin to Procalcitonin Ratio to Differentiate Patients with COVID-19 from Those with Bacterial Pneumonia
por: Jankousky, Katherine C, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ncpudkat60j6ojkv09kdkqnivc